ClinicalTrials.Veeva

Menu

pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts

S

San Donato Group (GSD)

Status

Completed

Conditions

Infertility

Treatments

Procedure: Laser assisted hatching

Study type

Interventional

Funder types

Other

Identifiers

NCT03623659
ALADDIN

Details and patient eligibility

About

The aim of study is to assess the possible impact of assisted hatching on delivery rate after transfer of vitrified-warmed human blastocysts.

Full description

Zona pellucida (ZP) manipulation, termed "assisted hatching" (AH), has been introduced in order to favor embryo hatching and ultimately improve assisted reproductive technology success but with poor proofs of safety and biological plausibility.

Vitrifying and warming of blastocysts may impair the successful hatching process of the embryo out of its ZP and its following implantation into the uterus. Theoretically, AH may facilitate the hatching process and subsequently increase implantation rates.

In this prospective randomized controlled trial (RCT), the hypothesis is to test whether the application of a partial AH to vitrified/warmed blastocysts might affect patients' delivery rate.

Patients with vitrified blastocysts will be randomized at the time of blastocyst warming to a study group (with AH) or a control group (without AH). AH will be performed at the expanded blastocyst stage using a laser technique and a laser opening will be initiated at the 1 o'clock position. Consecutive laser shots will be applied to reach the 5 o'clock position of the blastocyst. The blastocysts will then be cultured at least 2 h and subsequently transferred into the patient's uterus.

Enrollment

700 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • single embryo transfer of vitrified/warmed blastocyst (SET)
  • first or second frozen IVF (with or without Intracytoplasmic Sperm Injection) cycle of blastocysts
  • first or second oocyte retrieval

Exclusion criteria

  • Preimplantation Genetic Testing (PGT) cycle
  • BMI > 35 kg/m2
  • severe male factor
  • abnormal uterine cavity

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

700 participants in 2 patient groups

AH group
Active Comparator group
Description:
Subjects whose vitrified/warmed blastocysts will be subjected to the treatment of laser assisted hatching
Treatment:
Procedure: Laser assisted hatching
Control group
No Intervention group
Description:
Subjects whose vitrified/warmed blastocysts will be subjected to the same procedures except for the treatment of laser assisted hatching

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems